Dr. Polonis has coordinated regional labs in Thailand and East Africa for the Duke University Comprehensive Antibody Vaccine Immune Monitoring Consortium (CA - VIMC) funded by the Bill and Melinda Gates Foundation, and is a standing member of the HIV
Vaccines Study Section for the Center for Scientific Review at the NIH.
If the
vaccine is just a little bit different to the target virus, it is not expected to offer much protection,» said principal investigator of the
study Jeffery Taubenberger, MD, PhD, Chief of Viral Pathogenesis and Evolution
Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID).